What stage does Ventura BioMed Investors invest at?

Ventura BioMed Investors invests at the Seed, Series A stages.

What is Ventura BioMed Investors's typical check size?

Ventura BioMed Investors typically writes checks of $1.1M – $5.5M.

What sectors does Ventura BioMed Investors focus on?

Ventura BioMed Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Ventura BioMed Investors located?

Ventura BioMed Investors is headquartered in Munich, DE.

Does Ventura BioMed Investors lead rounds?

Ventura BioMed Investors typically participates in rounds rather than leading them.

Ventura BioMed Investors

Venture capital

Munich · Seed–Series A · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Ventura BioMed Investors focuses on early-stage life science companies developing pioneering technologies and innovative therapies. It typically invests EUR 1-5 million per company, always co-investing in consortia with other funds and within Europe. The firm can further expand its reach through Ventura Ace, an investment platform of selected private investors. Led by serial biotech and pharmaceutical entrepreneurs, the firm helps shape the long-term development of its portfolio companies and provides them with access to a broad investor and business network to accelerate medical breakthroughs.

Invests inBiotech Digital Health Healthtech Medical DevicesEuropeGermanyMunichSwitzerland

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Check

$1.1M – $5.5M

Munich, DE

Leads rounds

Follows

Instruments

Equity

Tracked investments

Team · 2 people

from the firm's website & public directories

Kurt Rudolf Schwarz· Dr.

An active investor and business angel engaged in numerous healthcare companies and various cultural and philanthropic institutions. A former supervisory board member of Schwarz Pharma representing the Schwarz family, he has also been affiliated with Merck & Co., Harvard Medical School, and Massachusetts General Hospital as a scientist and physician.

Andreas Jenne· Dr.

A serial biotech entrepreneur who has founded and led several companies, including as CEO of Kinaxo (acquired by Evotec) and NEO New Oncology (acquired by Siemens Healthcare). He serves as a board member in various biotech and medtech companies and holds a Ph.D. in Chemistry from Ludwig-Maximilians-University Munich.

j•••@ventura-biomed.comreveal

What they invest in

from 1 of 5 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 5 tracked

founders shown can be your intro path

Abalos Therapeutics

Biotech developing ABX-001, with anti-tumoral effects enhanced in combination with bispecific T-cell engagers.

arcoris bio

Swiss life science research tools and in vitro diagnostics company with the MUSE nanotechnology platform for biomarker detection.

iQure Pharmaiqurepharma.comin

BiotechSkillman, US

Pawel Zolnierczyk(Executive Officer)

Kupando

Immuno-oncology company developing KUP101, a dual TLR 4 and 7 agonist harnessing innate immune stimulation.

TQ Therapeutics

Biotech advancing cellular therapies via an ultra-short extracorporeal cell and gene therapy platform and proprietary cell selection technology.

Frequently asked questions

What stage does Ventura BioMed Investors invest at?: Ventura BioMed Investors invests at the Seed, Series A stages.
What is Ventura BioMed Investors's typical check size?: Ventura BioMed Investors typically writes checks of $1.1M – $5.5M.
What sectors does Ventura BioMed Investors focus on?: Ventura BioMed Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Ventura BioMed Investors located?: Ventura BioMed Investors is headquartered in Munich, DE.
Does Ventura BioMed Investors lead rounds?: Ventura BioMed Investors typically participates in rounds rather than leading them.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

Future Positive Capital

Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.